HeliosX Group vs Nourish: Revenue, Funding & Team Size Compared
HeliosX Group generates $69.9M in revenue; Nourish generates $111.9M. Nourish is 1.6× bigger than HeliosX Group by revenue. The table below compares HeliosX Group and Nourish on funding, valuation, customers, team size and headquarters — every figure GetLatka has verified for each company.
| Company |  HeliosX GroupThis company |  Nourish |
|---|---|---|
| Revenue | $69.9M | $111.9M |
| Valuation | Not disclosed | $1B |
| Funding raised | Not disclosed | $70M |
| Team size | 619 | 2.2K |
| Founded | 2013 | 2021 |
| HQ | London, United Kingdom | New York, United States |
Want the full dataset? GetLatka tracks revenue, funding and team history for thousands of SaaS companies, with charts, growth rates and founder interviews.
HeliosX Group at a glance
HeliosX Group generates $69.9M in revenue with 619 employees, headquartered in London, United Kingdom.
- Revenue
- $69.9M
- Team size
- 619
- Founded
- 2013
HeliosX is a digital health group dedicated to improving the quality, accessibility and affordability of healthcare for everyone.
Nourish at a glance
Nourish generates $111.9M in revenue with 2.2K employees, headquartered in New York, United States.
- Revenue
- $111.9M
- Valuation
- $1B
- Funding
- $70M
- Team size
- 2.2K
- Founded
- 2021
Telehealth dietitians covered by insurance
Other HeliosX Group alternatives
HeliosX Group competes with more than the companies on this page. Browse the full alternative lists to compare revenue, funding and team size across the category.
HeliosX Group vs Nourish: frequently asked questions
Is HeliosX Group or Nourish bigger?
Nourish is the bigger company by revenue, at $111.9M against $69.9M for HeliosX Group.
How much revenue does HeliosX Group make?
HeliosX Group generates $69.9M in annual revenue with a team of 619.
How much revenue does Nourish make?
Nourish generates $111.9M in annual revenue with a team of 2.2K.
How much funding has Nourish raised?
Nourish has raised $70M in total funding since it was founded in 2021.